Drug Metabolism and Pharmacokinetics, Drug Developmental Research Laboratories, Shionogi & Co., Ltd., Toyonaka, Osaka 561–0825, Japan.
Biol Pharm Bull. 2011;34(8):1187-93. doi: 10.1248/bpb.34.1187.
In this study, we developed a novel methodology, multiple injection method (MIM), for higher-throughput screening of compounds by liquid chromatography-tandem mass spectrometry (LC-MS/MS). MIM involves continuous injections of multiple samples containing a different compound respectively into the column, and then temporarily trapping of analytes at the column head in high-pressure liquid chromatography (HPLC) system. This is followed by elution of all the compounds from the column and detection of them by MS/MS. In this study, fexofenadine, verapamil, risperidone, ondansetron, and imipramine were used as model compounds to investigate the effectiveness of MIM in pharmacokinetic studies. Analytical time of validation samples of these model compounds could be shortened to one third by MIM, compared with the conventional method. In addition, both the accuracy and precision of MIM met the general criteria for quantitative analysis. The peak intensity was found to be unaffected by overlapping compounds even if they have wide range of ionization efficiency. As a result of the comparison of MIM and conventional method in the analysis of samples in pharmacokinetic studies using model compounds, no difference was shown in the quantification values. Consequently, this method has some advantages, reduction of analytical time, the improvement of sensitivity, and the simplicity of system, compared to the conventional methods. MIM should be very useful and powerful method for drug development without an additional hardware and can be used for the measurement of compounds in biological samples for pharmacokinetic studies, especially it greatly contributes to accelerating drug development in its discovery stages.
在这项研究中,我们开发了一种新的方法,即多次进样法(MIM),用于通过液相色谱-串联质谱(LC-MS/MS)进行高通量化合物筛选。MIM 涉及连续注入多个分别含有不同化合物的样品到色谱柱中,然后在高压液相色谱(HPLC)系统中将分析物暂时捕获在柱头上。接着,从色谱柱中洗脱所有化合物并通过 MS/MS 进行检测。在这项研究中,我们使用非索非那定、维拉帕米、利培酮、昂丹司琼和丙咪嗪作为模型化合物,以研究 MIM 在药代动力学研究中的有效性。与传统方法相比,MIM 可以将这些模型化合物的验证样品的分析时间缩短至三分之一。此外,MIM 符合定量分析的一般标准,其准确性和精密度均得到满足。即使重叠化合物具有广泛的电离效率,其峰强度也不受影响。通过在使用模型化合物的药代动力学研究中对样品进行 MIM 和传统方法的比较,在定量值方面没有显示出差异。因此,与传统方法相比,这种方法具有一些优势,例如分析时间缩短、灵敏度提高和系统简化。MIM 应该是一种非常有用且强大的方法,无需额外的硬件,可用于测量药代动力学研究中生物样品中的化合物,特别是在加速药物发现阶段的药物开发方面有很大的贡献。